The Merck Animal Health Prestige 5 +WNV Horse Vaccine has been shown to be effective for the vaccination of healthy horses 6 months of age or older against Eastern and Western encephalomyelitis viruses, EIV, EHV-1, EHV-4, tetanus, and West Nile Virus. Duration of immunity from the horse vaccine has been shown at 6 months for EIV. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov. This product has been shown to decrease virus shedding of EIV, EHV-1 and EHV-4, as well as to decrease encephalitis and viremia caused by West Nile Virus. Foals nursing immune-dams should be vaccinated when maternal antibody levels will allow active immunization.

• Multiple antigen combination in WNV vaccine reduces need for several injections
• Available in 10-dose vials and 1 mL single-dose prefilled syringes
• Equine vaccine formulated to minimize reactions and maximize protection
• West Nile virus (WNV) is the leading cause of arbovirus encephalitis in horses and humans in the United States
• Tetanus, WNV, EEE and WEE are considered core vaccinations recommended by the AAEP vaccine guidelines and are indicated in the immunization program for all horses each year
• Provides 6 months of protection against EIV
• A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesvirus types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains EIV A/eq/Florida/RW/13, EIV A/Equine 2/Kentucky/02 American, EIV A/eq/Richmond/1/07, West Nile virus flavivirus chimera and tetanus toxoid
• Advanced filtration process through the Antigen Purification System (APS)